Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women-Reference-Cited by-同舟云学术

Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women

Published:2022-10-26 Issue:1 Volume:34 Page:179-188
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Fenwick Steven^ORCID,Vekariya Vishal,Patel Ronak,Hajela Pallavi,Modi Ketul,Kale Prashant,Nath Akshaya

Funder

Intas Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-022-06573-x.pdf

Reference19 articles.

1. Compston JE, McClung MR, Leslie WD (2019) Osteoporos Lancet 393:364–376. https://doi.org/10.1016/s0140-6736(18)32112-3

2. World Health Organization (2007) WHO Scientific Group on the assessment of osteoporosis at primary health care level: summary meeting report

3. May 5-7, 2004, Brussels, Belgium. Geneva, Switzerland: World Health Organization 1-17. https://www.who.int/chp/topics/Osteoporosis.pdf. Accessed 13 December 2021

4. Reginster JY, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38:4–9. https://doi.org/10.1016/j.bone.2005.11.024

5. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733. https://doi.org/10.1007/s00198-006-0172-4

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State;Clinical Pharmacology in Drug Development;2024-06-24

2. Side effects of drugs for metabolic bone disease;Side Effects of Drugs Annual;2023